Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Response to brentuximab vedotin plus CHP according to CD30 expression in the ECHELON-2 trial Illidge, T., Horwitz, S., Iyer, S., Bartlett, N., Kim, W. S., Belada, D., Feldman, T., Illes, A., Jacobsen, E., Huettmann, A., Zinzani, P. L., O'Connor, O., Mckay, P., Trepicchio, W., Miao, H., Fenton, K., Onsum, M., Manley, T., Advani, R. WILEY. 2020: 111–12
View details for Web of Science ID 000528597400151